Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 22, 2021 08:26 ET | Source: Todos Medical Ltd.

Todos Medical Receives Purchase Order for 50,000 Bottles of Tollovid Daily from Its European Distribution Partner T-Cell Protect Hellas S.A for Initial Market Launch in Greece

· T-Cell Protect is also evaluating expected demand for maximum strength Tollovid® New York, NY, and Tel Aviv, ISRAEL, Nov. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos...
November 19, 2021 07:30 ET | Source: Todos Medical Ltd.

Todos Medical Announces Completion of Enrollment for COVID-19 Oral Antiviral 3CLPro (Mpro) Inhibitor Tollovir Phase 2 Clinical Trial Interim Analysis in Severe and Critical Hospitalized Patients

Enrollment now paused in the randomized, double blind, placebo controlled clinical trial in severe and critical hospitalized COVID-19 patients to complete interim analysisData from the interim...
November 18, 2021 06:00 ET | Source: Todos Medical Ltd.

Todos Medical Announces Tollovid® Products Exclusive License & Distribution Agreement with T-Cell Protect Hellas S.A. Covering 30 Countries in Europe

The Agreement Calls for a Minimum of 500,000 Bottles in Sales Over 18 Months T-Cell Protect to Invest 1 Million Euros in Todos to Support Development of Tollovir, the Company’s 3CL Protease...
November 17, 2021 18:02 ET | Source: Todos Medical Ltd.

Todos Medical Announces Addition of Semi-Quantitative Titer Claims to the Emergency Use Authorization for the cPass Neutralizing Antibody Test

· Reauthorization of EUA expands beyond initial qualitative detection claim · CEO to appear on Cheddar News at 6:10pm tonight, November 17th, 2021 New York, NY, and Tel Aviv,...
November 16, 2021 13:18 ET | Source: Todos Medical Ltd.

Update: Todos Medical Reports Third Quarter 2021 Business and Financial Results

New York, NY, and Tel Aviv, ISRAEL, Nov. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related...
November 16, 2021 09:55 ET | Source: Todos Medical Ltd.

Todos Medical’s Provista Laboratory to Boost Top Line Through New Atlanta-based Reference Lab Agreement for COVID PCR, cPass Neutralizing Antibody & Respiratory Pathogen Panel Tests

New York, NY, and Tel Aviv, ISRAEL, Nov. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related...
November 15, 2021 19:18 ET | Source: Todos Medical Ltd.

Todos Medical Reports Third Quarter 2021 Business and Financial Results

New York, NY, and Tel Aviv, ISRAEL, Nov. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related...
November 02, 2021 09:05 ET | Source: Todos Medical Ltd.

Todos Medical Sees Significant Ramp Up in COVID PCR Testing Volume at Its Provista CLIA/CAP Lab with New Automation in Place

Automation enabled Provista to conduct over 7,600 PCR tests for the month of October, more than in the first 8 months of 2021 combinedCompany sees expanding testing for COVID PCR, neutralizing...
November 01, 2021 07:35 ET | Source: Todos Medical Ltd.

Todos Medical Announces 2nd Clinical Trial Site for Tollovir Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients

§ Interim Clinical Trial Data from Phase 2 expected in Q4/21 § Nature Neuroscience and Cell Reports publications highlight 3CLpro (Mpro)’s complementary mechanisms of virus replication and...
October 26, 2021 09:59 ET | Source: Todos Medical Ltd.

Todos Medical to Present at the Benzinga Global Small Cap Conference

New York, NY, and Tel Aviv, ISRAEL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related...